What makes a molecule an anaesthetic? Studies on the mechanisms of anaesthesia using a physicochemical approach

British Journal of Anaesthesia

Volumn 103, Issue 1, 2009, Pages 50-60

  Sear, J W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anaesthetics i.v.; Anaesthetics volatile; Comparative molecular field analysis; Model, computer simulation; Theories of anaesthetic agent action, molecular

Indexed keywords

ALFAXALONE; ALTHESIN; ANESTHETIC AGENT; CLOMETHIAZOLE; ELTANOLONE; ETOMIDATE; KETAMINE; MINAXOLONE; OCTANOL; THIAMYLAL; THIOPENTAL; WATER; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPUTER PROGRAM; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG POTENCY; DRUG STRUCTURE; ELECTRICITY; GENERAL ANESTHESIA; HUMAN; MEDICAL RESEARCH; MOLECULAR MODEL; MOLECULE; PHARMACOPHORE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; STATIC ELECTRICITY;

ANESTHETICS; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; CHEMISTRY, PHYSICAL; COMPUTER SIMULATION; HUMANS; MODELS, MOLECULAR; STATIC ELECTRICITY;

EID: 67650744670     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep092     Document Type: Review

References (86)

1. Abraham MH. Scales of hydrogen bonding: their construction and application to physicochemical and biochemical processes. Chem Soc Rev 1993; 22: 73-83
2. Abraham MH, Acree WE, Mintz C, Payne S. Effect of anesthetic structure on inhalation anesthesia: implications for the mechanism. J Pharm Sci 2008; 97: 2373-84
3. Angel A. The GL Brown lecture: adventures in anaesthesia. Exp Physiol 1991; 76: 1-38
4. Becker KE, Jr, Tonneson AS. Cardiovascular effects of plasma levels of thiopental necessary for anesthesia. Anesthesiology 1978; 49: 197-200
5. Brandt W, Barth A, Holtje H-D. A new consistent model explaining structure (conformation)-activity relationships of opiates with μ-selectivity. Drug Design Discov 1993; 10: 257-83
6. Bronowska A, Les A, Mazgajska M, Chilnonczyk Z. Conformational analysis and pharmacophore design for selected 1-(2-pyrimidinyl) piperazine derivatives with sedative-hypnotic activity. Acta Pol Pharm 2001; 58: 79-86
7. Caravella JA, Richard WG. The potencies of optically active anaesthetics. Eur J Med Chem 1995; 30: 727-8
8. Child KJ, Gibson W, Harnby G, Hart JW. Metabolism and excretion of Althesin (CT 1341) in the rat. Postgrad Med J 1972; 48: 37-42
9. Christensen JH, Andreasen F, Kristoffersen BM. Comparison of the anaesthetic and haemodynamic effects of chlormethiazole and thiopentone. Br J Anaesth 1983; 55: 391-7
10. Coates DP, Monk CR, Prys-Roberts C, Turtle M. Hemodynamic effects of infusions of the emulsion formulation of propofol during nitrous oxide anesthesia in humans. Anesth Analg 1987; 66: 64-70
11. Cordata DJ, Chebib M, Herkes GK, Mather LE. Pharmacokinetics of thiopentone enantiomers following intravenous injection or prolonged infusion of rac-thiopentone. Br J Clin Pharmacol 1997; 42: 355-62
12. Cordato DJ, Chebib M, Mather LE, Herkes GK, Johnston GAR. Stereoselective interaction of thiopentone enantiomers with the GABA(A) receptor. Br J Pharmacol 1999; 128: 77-82
13. Cramer RD, Patterson DE, Bruce JD. Comparative molecular field analysis (CoMFA). Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988; 110: 5959-67
14. Dodson BA, Braswell LM, Miller KW. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes. Mol Pharmacol 1987; 32: 119-26
15. Downie DL, Franks NP, Lieb WR. Effects of thiopental and its optical isomers on nicotinic acetylcholine receptors. Anesthesiology 2000; 93: 774-83
16. Dundee JW. Molecular structure-activity relationships of barbiturates. In: Halsey MJ, Millar RA, Sutton JA eds. Molecular Mechanisms in General Anaesthesia, Chapter 2. Edinburgh: Churchill Livingstone, 1974; 16-31
17. Eger EI, Koblin DD, Laster MJ, et al. Minimum alveolar anesthetic concentration values for the enantiomers of isoflurane differ minimally. Anesth Analg 1997; 85: 188-92
18. Eger EI, II, Zhang Y, Laster M, et al. Acetylcholine receptors do not mediate the immobilization produced by inhaled anesthetics. Anesth Analg 2002; 94: 1500-4
19. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367: 607-14
20. Frisch MJ, Del Bene JE. The electronic structure and electrostatics of nitrous oxide. Int J Quantum Chem Symp 1989; 23: 363-9
21. Geisslinger G, Hering W, Thomann P, Kroll R, Kamp HD, Brune K. Pharmacokinetics and pharmacodynamics of ketamine enantio-mers in surgical patients using a stereoselective analytical method. Br J Anaesth 1993; 70: 666-71
22. Graf BM, Boban M, Stowe DF, Kampine JP, Bosnjak ZJ. Lack of stereospecific effects of isoflurane and desflurane isomers in isolated guinea pig hearts. Anesthesiology 1994; 81: 129-36
23. Haley TJ, Gidley JT. Pharmacological comparison of R(+), S(-) and racemic thiopentone in mice. Eur J Pharmacol 1976; 36: 211-4
24. Halsey MJ. A reassessment of the molecular structure-functional relationships of the inhaled general anaesthetics. Br J Anaesth 1984; 56: 9s-25s
25. Harris BD, Moody EJ, Skolnick P. Stereoselective actions of halothane at GABA(A) receptors. Eur J Pharmacol 1998; 341: 349-52
26. Hering WJ, Ihmsen H, Langer H, et al. Pharmacokinetic-pharma- codynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers. Anesthesiology 1996; 85: 1290-9
27. Illievich UM, Petricek W, Schramm W, et al. Electroencephalographic burst suppression by propofol infusion in humans: hemodynamic consequences. Anesth Analg 1993; 77: 155-60
28. James R, Glen JB. Synthesis, biological evaluation and preliminary structure-activity considerations of a series of alkylphenols as intravenous anaesthetic agents. J Med Chem 1980; 23: 1350-7
29. Kendig JJ, Trudell JR, Cohen EN. Halothane stereoisomers: lack of stereospecificity in two model systems. Anesthesiology 1973; 39: 518-24
30. Koblin DD, Chortkoff BS, Laster MJ, et al. Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg 1994; 79: 1043-8
31. Koblin DD, Laster MJ, Ionescu P, et al. Polyhalogenated methyl ethyl ethers: solubilities and anesthetic properties. Anesth Analg 1999; 88: 1161-7
32. Krasowski MD, Harrison NL. General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci 1999; 55: 1278-303
33. A receptor. J Med Chem 2002; 45: 3210-21
34. Kubinyi H. QSAR and 3D QSAR in drug design. Part 1: methodology. Drug Discov Today 1997; 11: 457-67
35. Larsen R, Lange H, Rathgeber J. Myocardial metabolism as affected by propofol in geriatric patients. A comparison with etomidate. Anaesthesist 1988; 37: 510-6
36. Le Normand Y, de Villepoix C, Pinaud M, et al. Pharmacokinetics and haemodynamic effects of prolonged methohexitone infusion. Br J Clin Pharmacol 1988; 26: 589-94
37. LePage JY, Pinaud ML, Helias JH, et al. Left ventricular performance during propofol or methohexital anesthesia: isotopic and invasive cardiac monitoring. Anesth Analg 1991; 73: 3-9
38. Liu J, Laster MJ, Taheri S, et al. Is there a cut-off in anesthetic potency for the normal alkanes? Anesth Analg 1993; 77: 12-8
39. Liu J, Laster MJ, Taheri S, et al. Effect of n-alkane kinetics in rats on potency estimations and the Meyer-Overton hypothesis. Anesth Analg 1994; 79: 1049-55
40. Lysko GS, Robinson JL, Casto R, Ferrone RA. The stereospecific effects of isoflurane isomers in vivo. Eur J Pharmacol 1994; 263: 25-9
41. Mark LC, Brand L, Perel JM, Carroll F, III. Barbiturate stereo-isomers: direction for the future? Excerpta Med Int Congr Ser 1977; 399: 143-6
42. Mather LE, Seow LT, Gourlay GK, Roberts JG, Cousins MJ. Minaxolone, clinical effects and pharmacokinetics. Anaesthesia 1981; 36: 586-91
43. Mather LE, Seow LT, Roberts JG, Gourlay GK, Cousins MJ. Development of a model for integrated pharmacokinetic and pharmacodynamic studies of intravenous anaesthetic agents: application to minaxolone. Eur J Clin Pharmacol 1981; 19: 371-81
44. Mehdipour AR, Hemmateenejad B, Miri R. QSAR studies on the anesthetic action of some polyhalogenated ethers. Chem Biol Drug Des 2007; 69: 362-8
45. Meyer HH. Theorie der alkoholnarkose. Arch Exp Pathol Pharmakol 1899; 42: 109-18
46. Miller KW. The nature of sites of general anaesthetic action. Br J Anaesth 2002; 89: 17-31
47. Moody EJ, Harris BD, Skolnick P. The potential for safer anaesthesia using stereoselective anaesthetics. Trends Pharmacol Sci 1994; 15: 387-91
48. Nakaigawa Y, Akazama DS, Shimizu R, Ishii R, Yamato R. Effects of graded infusion rates of propofol on cardiovascular haemody-namics, coronary circulation and myocardial metabolism in dogs. Br J Anaesth 1995; 75: 616-21
49. Nguyen KT, Morgan DJ. Myocardial uptake of thiopental enantio-mers by the isolated perfused rat heart. Chirality 1996; 8: 477-80
50. Overton E. Studien uber die narkose zugleich ein beitrag zur allge-meinin pharmakologie. Jena: Verlag von Gustav Fischer, 1901.
51. Peng Y, Keenan SM, Zhang Q, Kholodovych V, Welsh WJ. 3D-QSAR comparative molecular field analysis in opioid receptor antagonists: pooling data from different studies. J Med Chem 2005; 48: 1620-9
52. Phillips GH. Structure-activity relationships in steroidal anesthetics. J Steroid Biochem 1975; 6: 607-13
53. Phillips GH, Ayres BE, Bailey EJ, et al. Water-soluble steroidal anaesthetics. J Steroid Biochem 1979; 11: 79-86
54. Piriou V, Chiari P, Lehot JJ, Foex P, Arvieux CC. Effects of propo-fol on haemodynamics and on regional blood flows in dogs submitted or not to a volaemic expansion. Eur J Anaesthesiol 1999; 16: 615-21
55. Pohorecki R, Howard BJ, Matsushita M, Stemmer PM, Becker GL, Landers DF. Isoflurane isomers differ in preservation of ATP in anoxic rat hepatocytes. J Pharmacol Exp Ther 1994; 268: 625-8
56. Prakash O, Dhasmana KM, Verdouw PD, Saxena PR. Cardiovascular effects of etomidate with emphasis on regional myocardial blood flow and performance. Br J Anaesth 1981; 53: 591-9
57. Prys-Roberts C, Sear JW, Low JM, Phillips K, Dagnino J. Hemodynamic and hepatic effects of methohexital infusion during nitrous oxide anesthesia in humans. Anesth Analg 1983; 62: 317-23
58. Puttick RM, Diedericks J, Sear JW, et al. Effect of graded infusion rates of propofol on regional and global left ventricular function in the dog. Br J Anaesth 1992; 69: 375-81
59. Ryder S, Way WL, Trevor AJ. Comparative pharmacology of the optical isomers of ketamine in mice. Eur J Pharmacol 1978; 49: 15-23
60. Schuttler J, Stanski DR, White PF, et al. Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokin Biopharm 1987; 15: 241-53
61. Sear JW, Prys-Roberts C. Dose-related haemodynamic effects of continuous infusions of Althesin in man. Br J Anaesth 1979; 51: 867-73
62. Sear JW, Prys-Roberts C, Gray AJ, et al. Infusions of minaxolone to supplement nitrous oxide-oxygen anaesthesia. A comparison with Althesin. Br J Anaesth 1981; 53: 339-50
63. Sewell JC, Halsey MJ. Shape similarity indices are the best predictors of substituted fluoroethane and ether anaesthesia. Eur J Med Chem 1997; 32: 731-7
64. Sewell JC, Halsey MJ. Molecular similarity analysis: an alternative approach to studying molecular mechanisms of anaesthesia. Toxicol Lett 1998; 100-101: 359-64
65. Sewell JC, Sear JW. Can molecular similarity-activity models for intravenous general anaesthetics help explain their mechanism of action? Br J Anaesth 2002; 88: 166-74
66. Sewell JC, Sear JW. Derivation of preliminary three-dimensional pharmacophoric maps for chemically diverse i.v. general anaesthetics. Br J Anaesth 2004; 92: 45-53
67. Sewell JC, Sear JW. Derivation of preliminary three-dimensional pharmacophores for non-halogenated volatile general anesthetics. Anesth Analg 2004; 99: 744-51
68. Sewell JC, Sear JW. Physico-chemical modelling of anaesthetic agents. Available from http://www.eurosiva.org/Archive/ Vienna2005/Speakerabstracts/ JCSewellAbstract.htm (accessed on 31 January 2009)
69. Sewell JC, Sear JW. Determinants of volatile general anesthetic potency: a preliminary three-dimensional pharmacophore for halogenated anesthetics. Anesth Analg 2006; 102: 764-71
70. Sneyd JR, Wright PM, Harris D, et al. Computer-controlled infusion of ORG 21465, a water soluble i.v. anaesthetic agent, into human volunteers. Br J Anaesth 1997; 79: 433-9
71. Subramanian G, Paterlini MG, Portoghese PS, Ferguson DM. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. J Med Chem 2000; 43: 381-91
72. Sueyasu M, Ikeda T, Tanitama T, et al. Pharmacokinetics of thiamy-lal enantiomers in humans. Int J Clin Pharmacol Ther 1997; 35: 128-32
73. Sueyasu M, Fujito K, Shuto H, et al. Protein binding and the metabolism of thiamylal enantiomers in vitro. Anesth Analg 2000; 97: 736-40
74. Tang Y, Wang HW, Chen KX, Ji RY. QSAR of 3-methylfentanyl derivatives studied with neural networks method. Acta Pharmacol Sin 1995; 16: 26-32
75. Thomson IA, Fitch W, Hughes RL, Campbell D, Watson R. Effects of certain i.v. anaesthetics on liver blood flow and hepatic oxygen consumption in the greyhound. Br J Anaesth 1986; 58: 69-80
76. Todd MM, Drummond JC, U HS. The hemodynamic consequences of high-dose methohexital anesthesia in humans. Anesthesiology 1984; 65: 495-501
77. Todd MM, Drummond JC, U HS. The hemodynamic consequences of high-dose thiopental anesthesia. Anesth Analg 1985; 64: 681-7
78. Tomlin SL, Jenkins A, Lieb WR, Franks NP. Stereoselective effects of etomidate optical isomers on gamma-aminobutyric acid type A receptors and animals. Anesthesiology 1998; 88: 708-17
79. Tomlin SL, Jenkins A, Lieb WR, Franks NP. Preparation of barbiturate optical isomers and their effects on GABA(A) receptors. Anesthesiology 1999; 90: 1714-22
80. Trogdon G, Murray JS, Concha MC, Politzer P. Molecular surface electrostatic potentials and anesthetic activity. J Mol Modeling 2007; 13: 313-8
81. Urban BW. Current assessment of targets and theories of anaesthesia. Br J Anaesth 2002; 89: 167-83
82. Visser SAG, Smulders CJGM, Reijers BPR, et al. Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electro-encephalogram effects of alphaxalone in rats. J Pharmacol Exp Ther 2002; 302: 1158-67
83. Wang X-h, Tung Y, Xie Q, Qiu Z-b. QSAR study of 4-phenylpiperidine derivatives as μ-opioid agonists by neural network method. Eur J Med Chem 2006; 41: 226-32
84. White PF, Ham J, Way WL, Trevor AJ. Pharmacology of ketamine isomers in surgical patients. Anesthesiology 1980; 52: 231-9
85. White PF, Schuttler J, Shafer A, et al. Comparative pharmacology of the ketamine isomers. Br J Anaesth 1985; 57: 197-203
86. A nor strychnine-sensitive glycine are the sole mediators of MAC for isoflurane. Anesth Analg 2001; 92: 123-7